This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_GBM_EXALLC for full statistics.
Brain glioblastoma
C3_GBM
brain glioblastoma: A WHO grade IV malignant astrocytic tumor that arises from the brain, usually the cerebral hemispheres. It is characterized by the presence of poorly differentiated astrocytes, cellular polymorphism, nuclear atypia, and increased mitotic activity. The prognosis is poor.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditions
|
435 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
435 |
4. Check minimum number of eventsNone |
435 |
5. Include endpoints |
435 |
6. Filter based on genotype QC (FinnGen only) |
435 |
Control definitions (FinnGen only)
- Control conditions
- not HLP_C3_GBM
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Brain glioblastoma
based on the number of shared cases.
Similar with more cases:
- Brain glioblastoma, excluding all cancers (controls excluding all cancers)
- Brain glioblastoma and astrocytoma
- Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of brain
- Malignant neoplasm of eye, brain and central nervous system
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 435 | 177 | 258 |
| Unadjusted period prevalence (%) | 0.09 | 0.06 | 0.11 |
| Median age at first event (years) | 65.80 | 66.18 | 65.54 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 411
- Matched controls
- 4107
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
864.8
323.0
313
15
L01AX03
ATC
temozolomide; systemic
1354.8
321.9
273
6
H02AB02
ATC
dexamethasone; systemic
115.9
306.6
362
246
130
Kela drug reimbursment
Malignant tumour
61.4
248.3
311
198
N03AX14
ATC
levetiracetam; systemic
93.8
190.9
205
43
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
2251.5
161.7
146
*
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
245.0
147.6
144
9
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
36.4
141.0
186
91
9440/3-C71.9
ICD-O-3
Glioblastoma, NOS, of brain, NOS
+∞
139.8
126
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
24.7
136.1
207
162
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
68.0
131.4
149
34
C71.13
ICD-10 Finland
Malignant tumor of frontal lobe grade IV glioma
+∞
130.3
118
*
9440/3-C71.2
ICD-O-3
Glioblastoma, NOS, of temporal lobe
+∞
111.7
102
*
Z51.5
ICD-10 Finland
Palliative care
23.4
108.8
164
113
A04AA02
ATC
granisetron; systemic, transdermal
21.3
104.3
163
123
WF002
NOMESCO Finland
Radical radiotherapy
20.3
103.6
165
131
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
98.3
101.4
109
15
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
610.2
100.0
95
*
A03FA01
ATC
metoclopramide; systemic, rectal
10.7
99.2
246
503
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
207.9
95.8
96
6
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
158.1
94.7
97
8
9440/3-C71.1
ICD-O-3
Glioblastoma, NOS, of frontal lobe
+∞
93.4
86
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
27.9
92.8
130
67
ZXC95
NOMESCO Finland
Use of surgical navigator
73.9
90.1
101
18
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
+∞
85.5
79
*
C71.33
ICD-10 Finland
Malignant tumor of parietal lobe grade IV glioma
+∞
81.0
75
*
C71.1
ICD-10 Finland
Malignant neoplasm: Frontal lobe
+∞
79.8
74
*
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
911.7
79.1
75
*
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
168.1
68.3
70
5
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
23.9
65.4
95
51
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
185.4
61.9
63
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
233.4
59.8
60
*
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
+∞
58.8
55
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
75.5
57.2
64
10
AA1AD
NOMESCO Finland
CT of head and brain
5.8
56.5
215
654
XX3DW
NOMESCO Finland
Time consuming IT work
8.3
55.9
139
237
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
17.5
54.3
88
63
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
31.5
53.4
71
27
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
11.7
51.0
100
110
9440/3-C71.3
ICD-O-3
Glioblastoma, NOS, of parietal lobe
+∞
50.0
47
*
A04AA01
ATC
ondansetron; systemic, rectal
10.5
48.7
101
123
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
23.0
46.8
68
35
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.8
46.7
160
408
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
172.1
44.8
46
*
C71.3
ICD-10 Finland
Malignant neoplasm: Parietal lobe
+∞
44.6
42
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
40.3
42.5
53
15
C71.83
ICD-10 Finland
Overall malignant tumor of the brain grade IV glioma
+∞
42.4
40
*
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
+∞
41.4
39
*
N03AX18
ATC
lacosamide; systemic
42.5
39.8
49
13
N74
ICPC
Malignant neoplasm nervous system
151.4
39.5
41
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
55.9
38.5
45
9
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
8.8
35.7
81
112
C71.99
ICD-10 Finland
Malignant tumor in unspecified localization in the brain other or unspecified histology
377.9
35.5
35
*
ZXM40
NOMESCO Finland
Use of fluorescent substance
135.2
35.3
37
*
ZXC40
NOMESCO Finland
Use of ultrasound
63.0
34.9
40
7
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.8
33.6
92
168
WX882
NOMESCO Finland
High dependency care
12.4
33.6
62
58
N03AF02
ATC
oxcarbazepine; oral
13.6
32.9
58
49
N02AA05
ATC
oxycodone; systemic
4.7
30.7
121
337
N05CD08
ATC
midazolam; nasal, systemic
18.1
30.2
47
29
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
54.4
29.9
35
7
A02BC02
ATC
pantoprazole; systemic
3.7
28.8
325
2089
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
8.2
28.0
65
92
AA1BD
NOMESCO Finland
Extensive CT of head and brain
14.2
27.9
48
38
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
3.2
26.5
192
873
R56.8
ICD-10 Finland
Other and unspecified convulsions
7.7
26.5
64
96
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
26.3
25
*
C71.93
ICD-10 Finland
Malignant tumor in an unspecified localization in the brain grade IV glioma
277.1
26.0
26
*
WX402
NOMESCO Finland
General anaesthesia
4.1
25.4
114
352
A28
ICPC
Limited function/disability NOS
3.9
24.3
115
371
G40.9
ICD-10 Finland
Epilepsy, unspecified
10.6
22.4
44
46
A98
ICPC
Health maint/preventive medicine
0.3
22.3
268
3531
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
+∞
22.1
21
*
C71.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of brain
+∞
22.1
21
*
WZC30
NOMESCO Finland
Teaching
3.7
21.2
105
348
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
+∞
20.0
19
*
9440/3-C71.0
ICD-O-3
Glioblastoma, NOS, of cerebrum
+∞
20.0
19
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
24.0
19.3
27
12
C71.03
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade IV glioma
+∞
18.9
18
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
11.5
17.8
33
31
ZX070
NOMESCO Finland
Intensity modified radiotherapy
10.2
17.8
35
37
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
3.1
16.7
106
414
AAA10
NOMESCO Finland
Biopsy through craniotomy
176.9
16.6
17
*
N03AB02
ATC
phenytoin; systemic
16.2
16.4
26
17
N05CF01
ATC
zopiclone; oral
2.5
16.1
173
928
C71.80
ICD-10 Finland
Overall malignant tumor of the brain without histology
88.5
15.7
17
*
C71.19
ICD-10 Finland
Malignant tumor of frontal lobe other or unspecified histology
166.1
15.6
16
*
C71.9
ICD-10 Finland
Malignant neoplasm: Brain, unspecified
166.1
15.6
16
*
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
15.6
15.6
25
17
WX872
NOMESCO Finland
Intensive care
4.7
15.3
54
129
A79
ICPC
Malignancy NOS
14.7
15.2
25
18
9440/3-C71.8
ICD-O-3
Glioblastoma, NOS, of overlapping lesion of brain
+∞
14.7
14
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
155.3
14.6
15
*
TPH04
NOMESCO Finland
Cathetrisation of vein
2.6
14.4
123
573
WF004
NOMESCO Finland
Palliative radiotherapy
11.5
14.2
26
24
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
44.2
14.2
17
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
14.1
110
484
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
55.3
13.9
16
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
55.3
13.9
16
*
R4120
NOMESCO Finland
Occupational therapy
4.5
13.8
50
123
N76
ICPC
Neoplasm nervous system unspecified
144.6
13.5
14
*
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
17.4
13.1
20
12
XA800
NOMESCO Finland
Neuropsychological investigation
5.6
12.9
38
74
G40.10
ICD-10 Finland
Simple partial seizures
33.2
12.7
16
5
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
+∞
12.6
12
*
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
+∞
12.6
12
*
H53.4
ICD-10 Finland
Visual field defects
7.3
12.3
29
42
G41.9
ICD-10 Finland
Status epilepticus, unspecified
13.9
12.1
20
15
N05BA09
ATC
clobazam; oral
36.1
11.3
14
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
17.7
11.3
17
10
WX704
NOMESCO Finland
Intubation
3.7
10.7
48
143
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
112.8
10.5
11
*
C71.39
ICD-10 Finland
Malignant tumor of parietal lobe other or unspecified histology
+∞
10.5
10
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
+∞
10.5
10
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
5.7
10.3
29
54
B01AB10
ATC
tinzaparin; parenteral
3.5
10.3
49
154
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
17.2
9.9
15
9
XX9BW
NOMESCO Finland
Submitting image material and/or investigation material to authority or other institution
9.9
9.9
19
20
C71.32
ICD-10 Finland
Malignant tumor of parietal lobe grade III glioma
+∞
9.4
9
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
11.0
9.4
17
16
N03AG01
ATC
valproic acid; systemic, rectal
3.9
9.3
38
105
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.1
9.3
36
95
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
11.0
8.9
16
15
WX725
NOMESCO Finland
Noninvasive ventilation
4.3
8.8
32
80
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
16.7
8.6
13
8
WX408
NOMESCO Finland
General anesthesy, balanced
2.0
8.5
131
775
C71.01
ICD-10 Finland
Malignant tumor of cerebellum except lobes and ventricles grade II glioma
91.9
8.4
9
*
TKC20
NOMESCO Finland
Catheterisation of bladder
3.2
8.2
42
140
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
8.4
8.2
17
21
N05BA04
ATC
oxazepam; oral
2.1
8.1
112
633
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
17.6
8.1
12
7
SAA02
NOMESCO Finland
Basic examination of mouth
0.5
7.9
130
1896
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
8.7
7.9
16
19
XF400
NOMESCO Finland
ECG with 12 standard connections
2.2
7.8
85
435
R4110
NOMESCO Finland
Physiotherapy
2.0
7.7
122
725
R41.0
ICD-10 Finland
Disorientation, unspecified
5.2
7.5
22
44
G93.6
ICD-10 Finland
Cerebral oedema
81.5
7.4
8
*
SPAT1245
SPAT
Provision of support and information to patient’s family members
4.0
7.4
28
73
C71
ICD-10 Finland
Malignant neoplasm of brain
+∞
7.3
7
*
C71.0
ICD-10 Finland
Malignant neoplasm: Cerebrum, except lobes and ventricles
+∞
7.3
7
*
JN4BD
NOMESCO Finland
Extensive body CT
2.4
7.3
62
282
H02AB09
ATC
hydrocortisone; systemic
6.2
7.2
18
30
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
7.1
26
66
WX110
NOMESCO Finland
Local anesthesy
1.8
7.1
271
2145
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
6.9
159
2157
205
Kela drug reimbursment
Chronic hypertension
0.4
6.8
44
866
SFA10
NOMESCO Finland
Fillning on one surface of tooth
0.5
6.8
101
1534
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.4
6.8
27
638
N03AX23
ATC
brivaracetam; systemic
40.7
6.8
8
*
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.1
6.6
*
262
XA400
NOMESCO Finland
EEG
12.5
6.6
11
9
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
6.6
44
853
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
6.5
54
242
G41.2
ICD-10 Finland
Complex partial status epilepticus
70.9
6.4
7
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
5.1
6.4
19
39
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
18.4
6.3
9
5
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
6.3
6
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
27.1
6.2
8
*
M75.1
ICD-10 Finland
Rotator cuff syndrome
0.4
6.2
29
644
ZSA00
NOMESCO Finland
Procedure related to previous procedure classified in chapter A
12.8
6.1
10
8
R47.0
ICD-10 Finland
Dysphasia and aphasia
8.8
6.1
12
14
WX892
NOMESCO Finland
Monitored bed care
2.7
6.1
42
169
M25.5
ICD-10 Finland
Pain in joint
0.4
6.0
37
744
R83
ICPC
Respiratory infection other
0.3
6.0
15
436
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
117
22
72.38
211.61
1.8
1.5
—
—
—
0
0
(4035726)
252
325
17.05
206.74
1.3
1.4
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
99
0
+∞
107.91
1.1
0.0
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
216
598
6.19
79.25
1.9
1.9
s
26.6
29.5
9.41
207
580
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
126
206
8.20
78.64
3.5
10.1
mmol/l
24.2
24.6
1.06
126
194
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
181
450
6.18
74.09
4.5
7.6
kpa
4.8
5.1
4.98
176
432
(3027801) Oxygen [Partial pressure] in Arterial blood
181
450
6.18
74.09
4.5
7.6
kpa
18.1
12.1
19.51
176
435
(3003396) Base excess in Arterial blood by calculation
181
452
6.15
73.68
4.5
7.7
mmol/l
0.9
1.2
0.71
133
366
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
46
28
18.25
55.51
1.0
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
39
31
13.72
40.57
1.7
1.2
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
237
3522
0.28
36.62
3.0
4.7
mmol/l
4.9
4.6
2.61
210
3247
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
249
3598
0.28
36.20
3.2
5.3
mmol/l
3.0
2.7
3.31
219
3291
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
237
3506
0.29
35.25
3.0
4.7
mmol/l
1.4
1.4
0.14
212
3208
(3044640) Blood type and Crossmatch panel - Blood
235
1127
3.36
34.23
2.1
2.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
264
1376
3.34
33.09
3.2
2.1
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
27
16
17.93
32.65
1.7
1.2
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
236
1191
3.15
30.52
9.5
5.6
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
31
27
12.29
30.35
1.8
1.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
191
859
3.18
30.12
1.9
2.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
44
64
7.54
29.40
1.9
1.3
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
25
16
16.52
29.05
1.6
1.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
228
3349
0.33
28.35
4.0
6.1
mmol/mol
40.4
40.3
0.03
211
3093
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
247
3482
0.33
27.88
4.1
4.8
mmol/l
6.2
6.0
0.46
216
3163
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
237
3398
0.34
27.13
2.9
4.2
mmol/l
1.3
1.3
0.21
213
3099
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
24
19
13.31
24.79
1.5
1.2
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
42
76
6.01
22.72
1.9
1.2
e6/l
48.1
16.4
0.54
36
62
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
42
76
6.01
22.72
2.0
1.3
e6/l
5152.8
1472.6
0.47
36
65
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
22
18
12.82
22.23
1.3
2.1
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
270
1640
2.70
22.14
5.5
6.1
mmol/l
1.2
1.2
5.35
264
1482
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
22
19
12.14
21.51
1.3
2.0
%
16.5
13.5
—
10
10
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
43
85
5.50
21.18
1.6
1.2
mg/l
966.5
480.8
1.74
43
80
(3013650) Neutrophils [#/volume] in Blood by Automated count
308
2033
2.76
20.78
18.7
9.6
e9/l
4.9
4.1
6.62
278
1798
(3023410) Appearance of Cerebral spinal fluid
27
34
8.40
20.23
2.2
1.4
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
265
1651
2.55
19.73
9.9
5.9
%
1.3
2.9
32.14
260
1534
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
278
1777
2.56
19.50
6.4
7.0
mmol/l
1.2
1.2
2.40
251
1510
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
262
1653
2.47
18.53
3.2
4.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
17
11.64
18.10
1.1
1.2
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
270
1751
2.43
17.60
9.9
5.8
e9/l
0.5
0.6
4.18
242
1522
(3006315) Basophils [#/volume] in Blood
270
1762
2.40
17.19
9.9
5.8
e9/l
0.0
0.0
15.08
241
1540
(3019198) Lymphocytes [#/volume] in Blood
270
1781
2.36
16.49
10.1
5.9
e9/l
1.3
1.9
11.50
246
1587
(3003694) ABO and Rh group [Type] in Blood
168
905
2.40
16.48
1.2
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
274
1822
2.36
16.38
10.6
6.0
e9/l
0.1
0.2
40.09
242
1616
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
43
118
3.93
14.11
2.6
2.5
u/ml
0.4
0.4
0.06
32
68
(3032080) INR in Blood by Coagulation assay
234
1531
2.14
13.57
5.6
8.8
inr
1.1
1.2
2.13
65
435
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
59
208
3.12
13.19
6.4
10.2
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
335
3883
0.40
13.07
40.3
22.1
e9/l
7.7
6.7
9.97
322
3779
(3026361) Erythrocytes [#/volume] in Blood
335
3882
0.40
13.00
40.2
22.1
e12/l
4.4
4.5
6.32
322
3778
(3035941) MCH [Entitic mass]
335
3881
0.40
12.94
40.1
22.0
pg
31.0
30.4
7.63
330
3826
(3007461) Platelets [#/volume] in Blood
335
3879
0.41
12.81
40.4
22.1
e9/l
224.9
243.3
6.70
324
3785
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
119
1964
0.46
11.86
2.5
2.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
22
40
5.74
11.76
1.4
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
42
130
3.47
11.55
2.0
2.1
ug/l
110.1
309.1
2.67
42
123
(3001122) Ferritin [Mass/volume] in Serum or Plasma
68
1387
0.40
11.50
2.4
2.6
ug/l
204.5
149.9
0.70
57
1269
(3015377) Calcium [Moles/volume] in Serum or Plasma
188
1190
2.02
11.32
10.1
3.5
mmol/l
2.3
2.3
0.02
178
1039
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
22
42
5.46
11.18
1.3
1.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
247
3146
0.50
10.83
3.7
4.5
mu/l
1.8
2.0
1.58
220
2825
(3023368) Bacteria identified in Blood by Culture
169
1048
2.00
10.63
3.2
4.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
19
33
5.97
10.62
1.4
1.0
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
12
10.26
10.48
1.5
1.1
—
—
—
0
0
(40758558) Short blood count panel - Blood
148
881
2.03
10.40
14.8
7.1
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
1257
0.41
9.98
2.4
3.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
74
1395
0.43
9.91
1.7
2.2
nmol/l
75.8
76.9
0.11
68
1224
(3036481) Cortisol [Moles/volume] in Serum or Plasma
69
317
2.40
9.16
1.8
1.8
nmol/l
286.0
375.3
3.08
61
296
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
188
2551
0.54
9.11
3.4
3.7
pmol/l
14.7
14.8
0.29
170
2276
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
57
1160
0.41
9.07
1.8
3.1
ng/l
461.2
1242.7
6.05
50
996
(3013707) Erythrocyte sedimentation rate by Westergren method
197
2635
0.54
9.07
2.7
4.1
mm/h
12.2
12.4
0.05
176
2415
(3019060) Gas panel - Arterial blood
60
264
2.48
8.74
6.2
4.6
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
10
10
10.21
8.67
1.1
1.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
45
991
0.39
8.56
2.2
2.8
umol/l
11045.6
7665.4
0.12
37
836
(3012516) Albumin [Mass/volume] in Urine
58
1141
0.43
8.33
2.8
3.2
mg/l
42.1
223.8
1.13
36
724
(3000991) Gas panel - Venous blood
65
304
2.34
8.27
4.1
8.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
13
541
0.22
8.16
1.1
1.3
u/ml
1.1
9.2
—
5
199
(3021960) Folate [Moles/volume] in Serum or Plasma
39
879
0.39
7.70
1.3
1.6
nmol/l
19.1
21.1
0.53
34
742
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
11
6
18.76
7.63
1.2
1.7
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
11
6
18.76
7.63
1.2
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
10
12
8.51
7.61
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
65
1180
0.47
7.33
2.5
3.0
mmol/l
9.4
7.8
1.04
53
962
(3020682) Albumin/Creatinine [Ratio] in Urine
67
1202
0.48
7.30
3.2
3.9
mg/mmol
11.6
7.4
0.32
34
743
(40761511) CBC panel - Blood by Automated count
319
3645
0.53
7.30
23.1
14.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
62
300
2.24
7.27
2.7
4.7
%
1.4
0.9
1.24
33
98
(21494814) CD8 cells/100 lymphocytes in Specimen
11
7
16.07
7.26
1.2
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
102
1594
0.53
7.26
3.1
4.9
ug/l
2.2
2.4
0.16
84
1421
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
11
16
7.03
7.18
1.3
1.1
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
24
71
3.52
7.08
2.3
6.6
iu/ml
128.2
151.9
—
6
13
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
76
1276
0.51
6.66
2.8
4.3
%
21.7
21.2
0.16
33
607
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
94
1470
0.54
6.50
1.7
2.0
pmol/l
93.4
95.3
0.17
48
745
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
116
730
1.80
6.44
3.1
3.8
ng/l
50.9
283.7
3.09
90
592
(3024561) Albumin [Mass/volume] in Serum or Plasma
211
1567
1.67
6.43
5.5
4.9
g/l
33.8
35.4
4.40
203
1461
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
289
3366
0.58
6.39
26.2
14.1
ml/min/173m2
88.2
79.1
15.64
263
2788
(3002179) Metamyelocytes/100 leukocytes in Blood
54
265
2.18
6.11
2.6
4.8
%
0.4
0.3
0.23
19
69
(3051593) INR in Capillary blood by Coagulation assay
10
16
6.37
5.98
1.9
11.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
9
6
15.27
5.92
1.0
1.0
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
146
1010
1.67
5.69
2.4
3.2
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
5
16.25
5.43
1.1
1.4
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
17
49
3.57
5.22
1.2
2.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
151
1073
1.62
5.21
3.4
4.1
ph
7.4
7.4
0.01
27
196
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
694
0.45
5.04
1.2
1.2
u/ml
0.5
1.3
—
7
184
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
88
1328
0.58
5.03
3.2
3.8
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
122
1695
0.61
5.01
2.9
3.7
estimate
0.0
0.0
0.00
24
312
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
21
517
0.38
4.89
1.6
2.3
%
25.3
22.6
0.35
15
445
(3021601) Nitrite [Presence] in Urine by Test strip
124
1707
0.62
4.85
4.0
5.0
estimate
0.0
0.0
0.00
24
316
(4010399)
9
291
0.29
4.55
1.0
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
55
925
0.54
4.55
2.2
2.9
ug/l
0.6
0.7
1.13
32
607
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
44
224
2.07
4.54
1.4
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
8
10.16
4.53
1.0
1.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
101
673
1.65
4.41
4.0
3.3
mmol/l
2.4
2.5
0.04
90
592
(3009261) Glucose [Presence] in Urine by Test strip
129
1732
0.64
4.37
3.0
3.7
estimate
0.0
0.0
0.00
23
299
(3012501) Base excess in Blood by calculation
21
78
2.78
4.31
2.3
3.4
mmol/l
2.7
2.3
0.24
14
51
(3019150) Specific gravity of Urine by Refractometry
43
768
0.51
4.29
3.3
3.9
kg/l
1.0
1.0
0.04
13
102
(4094501)
0
108
0.00
4.26
0.0
1.1
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
58
931
0.56
4.02
3.3
3.9
estimate
0.0
0.0
0.50
21
305
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
8
11
7.38
3.87
1.3
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
8
11
7.38
3.87
1.3
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
49
277
1.87
3.78
2.9
4.9
%
0.2
0.1
0.13
31
89
(3024869) Neuronal Ab [Presence] in Serum
6
5
12.14
3.77
1.0
1.0
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
55
879
0.57
3.72
1.4
2.0
mg/l
3.0
3.2
0.15
42
749
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
10
25
4.07
3.72
1.0
1.1
mg/l
48.8
51.6
—
10
20
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
8
12
6.77
3.69
1.3
1.2
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
8
12
6.77
3.69
1.3
1.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
89
601
1.60
3.65
1.9
1.9
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
147
1110
1.49
3.64
2.5
3.2
e6/l
26.5
126.1
1.01
120
863
(3021589) Normoblasts [#/volume] in Blood
194
1549
1.46
3.60
16.7
9.8
e9/l
0.0
0.0
0.10
158
1285
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
230
0.29
3.57
1.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
14
358
0.37
3.54
1.3
1.5
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
6
6
10.12
3.50
1.2
1.3
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
25
499
0.47
3.44
1.0
1.3
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
135
1014
1.48
3.39
2.3
3.1
e6/l
0.5
0.5
0.21
111
762
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
82
1156
0.64
3.25
2.2
2.5
u/l
52.3
57.4
1.31
76
1061
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
18
72
2.56
3.25
1.4
1.5
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
18
72
2.56
3.25
1.4
1.5
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
66
426
1.65
3.23
1.6
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
0
83
0.00
3.16
0.0
1.3
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
129
977
1.46
3.07
2.4
3.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
48
755
0.59
3.01
1.3
1.7
pmol/l
492.7
6400430.2
0.50
38
625
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
499
0.51
2.96
1.1
1.4
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
11
288
0.37
2.95
1.2
1.4
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
13
46
2.88
2.94
1.8
2.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
13
46
2.88
2.94
1.2
2.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
6
9
6.74
2.87
1.5
1.3
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
65
433
1.59
2.81
1.6
1.9
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
5
6
8.41
2.75
1.2
1.0
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
128
2.01
2.61
2.1
1.7
—
—
—
0
0
(3000492) Spirometry study
17
348
0.47
2.53
1.4
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
22
411
0.51
2.51
1.0
1.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
82
590
1.48
2.50
2.0
3.0
e6/l
2.5
1.8
0.47
52
326
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
307
0.44
2.50
1.4
1.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
55
802
0.64
2.48
2.5
3.6
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
45
2.71
2.47
4.0
4.7
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
10
34
2.99
2.42
1.1
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
96
717
1.43
2.42
2.1
2.8
mosm/kgh2o
568.1
557.7
0.18
86
608
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
8
6.31
2.38
1.0
1.0
%
97.6
114.8
—
5
8
(3005322) IgE [Units/volume] in Serum or Plasma
8
202
0.38
2.36
1.0
1.3
u/ml
90.1
190.6
—
8
183
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
23
412
0.53
2.30
1.3
1.9
%
1.3
1.5
1.67
16
353
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
23
3.52
2.28
1.0
1.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
42
636
0.62
2.24
1.1
1.5
g/l
2.1
2.7
1.81
22
383
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
5
9
5.60
2.22
1.0
2.2
%
202.8
126.0
—
5
9
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
8
24
3.38
2.19
2.4
3.4
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
20
365
0.53
2.13
1.8
2.3
g/l
0.3
0.2
2.76
20
343
(1616796) Gas panel - Central venous blood
16
75
2.18
2.11
1.6
2.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
153
1262
1.33
2.07
2.7
3.8
e6/l
35.6
79.0
1.77
122
926
(3041096) Erythrocytes [Presence] in Urine by Automated
69
926
0.70
2.03
2.9
3.4
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
7
21
3.37
1.97
1.3
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
291
3165
0.76
1.96
30.8
16.2
%
39.3
40.2
0.86
204
2203
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
16
78
2.09
1.93
1.1
1.1
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
158
1326
1.30
1.85
2.6
3.2
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
8
29
2.79
1.80
1.0
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
30
465
0.62
1.78
8.8
7.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
81
623
1.37
1.72
2.1
2.8
e6/l
1.7
1.1
0.37
50
354
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
5
13
3.88
1.72
1.0
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
11
48
2.33
1.72
2.0
1.8
%
88.2
90.2
0.51
11
48
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
170
1453
1.28
1.71
3.5
3.7
ng/l
18.1
40.7
4.88
144
1066
(3002256) Pathology report gross observation
29
448
0.62
1.70
1.1
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
17
302
0.55
1.69
4.0
3.4
—
—
—
0
0
(4027681)
6
19
3.19
1.66
1.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
8
172
0.46
1.62
2.1
2.7
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
331
3511
0.76
1.61
27.8
15.2
mg/l
16.4
23.9
10.14
320
2802
(3002032) Base excess in Venous blood by calculation
47
333
1.46
1.58
2.2
3.6
mmol/l
2.1
1.9
0.18
42
269
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
33
483
0.66
1.53
3.1
4.6
%
29.7
31.6
0.62
24
308
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
58
431
1.40
1.52
1.9
2.9
umol/l
4.8
8.9
3.49
53
380
(3019225) pH of Specimen
49
354
1.43
1.50
3.2
4.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
213
0.50
1.46
1.5
1.8
—
—
—
0
0
(40768443) Skin Pathology biopsy report
7
154
0.45
1.46
1.0
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
235
2582
0.80
1.45
3.1
4.0
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
95
774
1.29
1.36
6.1
5.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
5
17
2.96
1.36
1.0
3.4
%
126.0
88.5
—
5
17
(3025159) Blasts/100 leukocytes in Blood
38
267
1.46
1.35
3.1
4.9
%
0.0
0.1
0.32
21
76
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
37
0.00
1.35
0.0
1.3
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
0
40
0.00
1.33
0.0
1.3
—
64.9
—
0
31
(3020191) Ethanol [Moles/volume] in Serum or Plasma
8
35
2.31
1.27
1.4
1.3
promille
0.4
1.3
—
8
29
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
189
0.52
1.25
1.5
1.8
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
6
26
2.33
1.19
3.8
3.3
—
—
—
0
0
(1002224) Polysomnography panel
8
153
0.51
1.16
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
13
220
0.58
1.14
1.0
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
10
182
0.54
1.13
1.7
1.2
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
73
1.80
1.12
1.2
1.5
—
—
—
0
0
(3012544) pH of Venous blood
46
348
1.36
1.12
2.2
3.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
13
74
1.78
1.08
1.2
1.3
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
91
762
1.25
1.05
2.4
2.5
e6/l
6.8
4.3
0.84
84
669
(3028707) Methadone [Presence] in Urine by Screen method
7
34
2.08
1.03
1.0
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
22
320
0.67
1.03
1.9
2.8
e9/l
66.3
70.1
0.22
15
247
(36660697) Celiac disease serology panel - Serum
14
224
0.61
1.01
1.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
132
0.52
1.00
1.3
4.7
—
2.1
—
0
17
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
0
29
0.00
0.98
0.0
1.4
—
24.0
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
7
36
1.96
0.97
4.0
3.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
50
1.82
0.97
2.7
2.6
e9/l
6.5
4.5
—
9
50
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
0
31
0.00
0.96
0.0
1.3
—
58.1
—
0
7
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
119
0.50
0.95
2.0
1.6
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
8
145
0.54
0.94
3.0
1.9
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
19
126
1.53
0.93
4.5
3.5
mmol/l
3.8
4.0
0.90
19
113
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
102
0.48
0.90
1.2
1.7
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
27
364
0.72
0.85
1.2
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
20
137
1.48
0.85
2.5
1.9
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
140
0.56
0.84
1.0
1.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
28
374
0.73
0.84
1.1
1.5
—
—
—
0
0
(4034850)
6
113
0.52
0.84
9.5
11.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
16
106
1.53
0.80
1.4
1.7
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
32
415
0.75
0.80
2.2
4.3
ug/l
3.7
38.9
1.11
20
349
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
0
24
0.00
0.79
0.0
1.3
—
12.7
—
0
9
(3044242) Glucose [Moles/volume] in Arterial blood
0
24
0.00
0.79
0.0
4.4
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.1
—
5.7
—
0
7
(1617658) Protocol used for examination of sentinel lymph nodes
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
26
0.00
0.78
0.0
6.7
—
39.1
—
0
8
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
26
0.00
0.78
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
27
0.00
0.77
0.0
1.0
—
—
—
0
0
(3036603) Volume of Urine
0
27
0.00
0.77
0.0
1.8
—
1858.0
—
0
5
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
15
99
1.53
0.76
1.3
1.7
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.2
—
0.1
—
0
16
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
28
0.00
0.76
0.0
1.6
—
28.6
—
0
5
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
53
1.71
0.76
3.0
3.0
%
68.0
57.3
—
9
53
(3013139) Helicobacter pylori Ag [Presence] in Stool
15
219
0.67
0.75
1.1
1.3
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
5
24
2.10
0.74
2.8
2.4
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
48
391
1.26
0.73
3.8
3.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
56
1.62
0.72
1.4
1.6
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
24
177
1.38
0.72
2.8
3.4
mmol/l
25.8
25.2
0.57
24
172
(3019309) Folate [Moles/volume] in Red Blood Cells
56
667
0.82
0.71
1.6
1.7
nmol/l
934.8
1206.7
2.35
41
497
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
41
1.72
0.70
1.4
1.1
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
58
487
1.22
0.68
9.4
23.0
inr
1.2
1.3
0.52
18
69
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
62
1.63
0.65
1.1
1.2
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
87
1.51
0.64
1.1
1.2
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
30
236
1.29
0.61
2.3
2.5
—
17.0
—
0
11
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
30
1.67
0.61
2.8
2.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
5
30
1.67
0.61
1.2
1.3
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
8
50
1.61
0.61
4.2
2.8
—
—
—
0
0
(44790047)
8
51
1.58
0.60
1.0
1.5
—
—
—
0
0
(44806118)
8
51
1.58
0.60
1.0
1.5
—
—
—
0
0
(44790048)
8
51
1.58
0.60
1.0
1.5
—
—
—
0
0
(44790049)
8
51
1.58
0.60
1.0
1.5
—
—
—
0
0
(3017704) Immunofixation for Urine
0
20
0.00
0.60
0.0
1.6
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
97
1.46
0.59
1.2
1.7
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
22
0.00
0.59
0.0
4.7
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
37
450
0.81
0.59
1.4
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
69
790
0.85
0.58
1.6
1.7
mg/l
3.6
1.3
1.34
58
601
(3023430) Cat dander IgE Ab [Units/volume] in Serum
0
23
0.00
0.58
0.0
1.1
—
6.7
—
0
7
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
27
212
1.29
0.57
1.3
1.4
—
42.2
—
0
16
(3042936) Bacteria identified in Isolate by Culture
47
555
0.83
0.56
1.5
2.0
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
5
90
0.55
0.56
1.0
1.5
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
66
1.53
0.53
1.1
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
66
1.53
0.53
1.1
1.3
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
63
1.44
0.52
1.4
1.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
99
0.60
0.52
1.3
4.8
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
37
443
0.82
0.52
1.8
2.6
%
1.9
1.8
0.14
30
399
(3052851) Hemolysis interference index of Serum or Plasma
15
109
1.39
0.51
4.4
3.1
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
57
494
1.18
0.50
6.3
6.9
mmol/l
105.0
104.1
0.93
57
480
(3018405) Lactate [Moles/volume] in Arterial blood
19
146
1.32
0.48
4.5
4.0
mmol/l
1.7
1.3
1.01
19
141
(3011288) Drugs identified in Urine by Screen method
7
49
1.44
0.46
1.0
1.4
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
22
175
1.27
0.44
2.3
2.4
%
0.7
0.7
0.01
22
170
(3004588) Protein electrophoresis panel - Serum or Plasma
21
262
0.79
0.43
1.1
3.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
29
348
0.82
0.43
1.1
1.7
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
2.3
—
16.6
—
0
15
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3001893) Eosinophils/100 leukocytes in Pleural fluid
0
15
0.00
0.41
0.0
1.3
—
1.5
—
0
10
(21491868) Cryoglobulin [Mass/volume] in Serum
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
0
16
0.00
0.41
0.0
1.3
—
62.5
—
0
10
(3044007) Cell count panel - Peritoneal fluid
0
16
0.00
0.41
0.0
1.6
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
0
16
0.00
0.41
0.0
1.4
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
16
0.00
0.41
0.0
1.9
—
4105.0
—
0
9
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
18
0.00
0.40
0.0
3.8
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
18
0.00
0.40
0.0
3.8
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
101
0.69
0.40
1.6
1.2
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
101
0.69
0.40
1.1
2.0
mg/l
11.2
12.7
—
7
93
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
12.6
—
932.2
—
0
19
(3023511) Choriogonadotropin [Units/volume] in Urine
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
15.3
—
1518.2
—
0
19
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
80
1.38
0.38
1.3
1.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
21
257
0.81
0.38
1.1
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
27
225
1.21
0.38
3.4
2.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
147
0.74
0.38
1.2
3.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
8
115
0.69
0.37
1.3
1.2
—
3.1
—
0
6
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
41
1.47
0.36
1.5
1.8
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
5
78
0.64
0.36
1.2
1.2
—
3.2
—
0
13
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
78
0.64
0.36
1.2
1.2
—
3.1
—
0
14
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
225
2337
0.92
0.34
4.2
3.3
u/l
78.7
53.6
0.92
217
2170
(1761482) Bacteria [#/volume] in Urine by Culture
13
100
1.31
0.34
3.1
5.0
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
15
188
0.79
0.34
1.2
1.2
iu/ml
122.3
126.8
—
5
71
(3037756) Immunofixation for Serum or Plasma
6
86
0.69
0.33
1.3
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
56
1.25
0.29
1.3
1.4
—
—
—
0
0
(3020891) Body temperature
18
149
1.22
0.28
5.1
4.3
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
63
1.27
0.28
1.0
1.1
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
289
0.86
0.27
3.1
3.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
8
65
1.24
0.27
1.5
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
13
104
1.26
0.26
1.7
2.1
%
118.0
88.4
2.69
13
97
(3037467) Urinalysis macro (dipstick) panel - Urine
247
2401
1.07
0.25
4.1
4.3
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
78
1.29
0.24
1.0
1.2
—
—
—
0
0
(4268621)
5
40
1.25
0.22
1.8
2.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
41
1.22
0.22
1.4
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
11
0.00
0.21
0.0
1.0
—
2.4
—
0
11
(3036071) Salmonella sp Ab [Titer] in Serum
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
10
0.00
0.21
0.0
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
18.8
—
0
10
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
8
101
0.79
0.21
1.5
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
8
102
0.78
0.21
1.5
1.2
—
—
—
0
0
(4015189)
0
12
0.00
0.21
0.0
2.7
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
12
0.00
0.21
0.0
6.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
0
12
0.00
0.21
0.0
1.1
—
0.8
—
0
6
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.2
—
230.3
—
0
13
(3048879) Bone marrow aspiration report
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
13
0.00
0.21
0.0
1.8
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.1
—
0.3
—
0
6
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
9.2
—
0
13
(3000764) Benzodiazepines [Presence] in Urine
10
80
1.26
0.20
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
13
155
0.83
0.20
1.5
1.3
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
52
1.16
0.19
1.0
1.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
37
339
1.10
0.18
1.4
2.3
ug/l
2.5
7.3
5.06
30
304
(3028300) Cannabinoids [Presence] in Urine
10
82
1.22
0.17
1.0
1.2
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
10
82
1.22
0.17
1.0
1.2
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
66
0.75
0.17
1.2
1.1
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
12
101
1.19
0.16
1.2
1.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
17
193
0.88
0.16
2.0
2.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
77
0.78
0.15
3.5
2.1
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
80
0.75
0.15
1.0
1.3
u/l
5.3
8.3
—
6
62
(3027944) Amphetamines [Presence] in Urine
9
81
1.11
0.15
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
7
90
0.77
0.14
1.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
17
151
1.13
0.13
1.1
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
132
1.14
0.13
1.5
3.2
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
25
230
1.09
0.11
2.5
3.1
g/l
137.4
129.0
1.52
25
225
(3030981) Hyaline casts [#/volume] in Urine by Automated count
22
201
1.10
0.11
2.9
2.9
e6/l
1.1
0.2
0.54
22
195
(46235355) HIV 1 and 2 tests - Meaningful Use set
42
443
0.94
0.10
1.2
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
45
1.11
0.10
1.0
1.1
—
—
—
0
0
(4306422)
5
47
1.06
0.09
1.0
1.3
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
15
165
0.91
0.09
2.1
3.6
u/ml
13.4
1583.1
—
10
141
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
55
1.09
0.09
1.0
1.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
56
1.07
0.08
1.7
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
430
1.05
0.08
1.7
1.6
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
(3013512) EKG study
108
1104
0.97
0.07
3.6
4.0
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
27
286
0.94
0.07
6.1
2.7
ml/min/173m2
73.8
63.6
0.73
12
120
(3042111) Morphology [Interpretation] in Bone marrow Narrative
8
78
1.03
0.07
1.1
1.6
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
85
0.82
0.07
1.9
1.6
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
189
1.06
0.04
2.0
3.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
93
1.08
0.02
1.2
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
23
223
1.03
0.01
1.4
1.7
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
10
96
1.04
0.00
1.3
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
16
157
1.02
0.00
2.2
3.8
mmol/l
25.1
25.1
0.00
16
147
(3000330) Specific gravity of Urine by Test strip
18
178
1.01
0.00
4.1
3.8
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
62
0.97
0.00
1.2
2.2
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
7
71
0.99
0.00
1.4
1.3
iu/l
18.3
22.8
—
7
60
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
5
56
0.89
0.00
1.0
1.2
mmol/l
7.0
7.8
—
5
38
(40768446) Kidney Pathology biopsy report
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.9
—
0
7
(3013293) Extractable nuclear Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
3.4
—
83.8
—
0
8
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
0
6
0.00
0.00
0.0
10.5
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
7
75
0.93
0.00
1.0
2.2
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
5
57
0.88
0.00
1.0
3.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
77
0.91
0.00
1.4
2.8
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
6
0.00
0.00
0.0
10.5
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
69
1.01
0.00
1.6
1.8
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
8
0.00
0.00
0.0
1.0
—
18.3
—
0
8
(3025315) Body weight
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
0
7
0.00
0.00
0.0
10.3
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
10.3
—
0
5
(3001186) Copper [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
18.1
—
0
5
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.6
—
98.2
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_GBM – Brain glioblastoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).